Presented by: The University of Texas at Austin
Move Your IP: Concept to Commercialization
Saturday, March 12
12:30PM - 1:30PM
3TEN Austin City Limits Live
310 Willie Nelson Blvd Ste 1A
This panel will illustrate, with real-life examples, how to take an idea (intellectual property) from a concept all the way through to commercialization, potentially bringing your idea/technology to market.
Our panel of experts will share their perspectives as: a Venture Capitalist and Co-Founder/CEO of a company that raised millions, a nationally recognized journalist, a Co-Founder of a startup from The University of Texas at Austin that was acquired by a global corporation and a United States Patent and Trademark Office executive who oversees outreach services for inventors, entrepreneurs, startups and researchers.
Co-Founder Pres & CEO
David G. Lowe, Ph.D., is Co-Founder, President & Chief Executive Officer, Aeglea BioTherapeutics: Dr. Lowe has been a research scientist managing and leading drug discovery efforts; a venture capit...Show the rest
David G. Lowe, Ph.D., is Co-Founder, President & Chief Executive Officer, Aeglea BioTherapeutics: Dr. Lowe has been a research scientist managing and leading drug discovery efforts; a venture capitalist investing in emerging and mid stage life science companies; and most recently a biotechnology entrepreneur. He started his career as a molecular biologist, joining Genentech in 1985 as a postdoctoral fellow and ultimately became a Research Director. Dr. Lowe was responsible for drug discovery activities in biologics and small molecule therapeutics, efforts that resulted in eight drugs that progressed to clinical development, including two eventual products. In 2002 he joined Palo Alto CA based Skyline Ventures as a Kauffman Fellow. As a Partner and later Managing Director Dr. Lowe led financings in start-ups to mid-stage therapeutics, diagnostics and platform technology companies. In 2013 he became co-founder and CEO of Aeglea BioTherapeutics, a University of Texas at Austin spin-out biotechnology company developing engineered human enzymes to treat inborn errors of metabolism and cancer. Dr Lowe is also on the Board of Directors and is Chair of the Investment Committee of MaRS Innovation, a start-up accelerator in Toronto Canada.Hide the rest
I am the national correspondent at Xconomy. I've spent most of my career covering business of every kind, from breweries in Oregon to investment banks in New York. A native of the Pacific Northwest...Show the rest
I am the national correspondent at Xconomy. I've spent most of my career covering business of every kind, from breweries in Oregon to investment banks in New York. A native of the Pacific Northwest, I began my reporting career at weekly and daily newspapers that still print the news, writing about murder trials, government policies, music, and more. I left the West Coast to pursue business journalism in New York, where I covered biotech and private equity for The Deal, and then the high-yield bond and leveraged loan markets for Bloomberg News. I left New York for Austin, TX, in 2014 and now focus on innovation in technology, life sciences, startups, and anything interesting for the 10 regions Xconomy covers nationally.Hide the rest
Dir of the Texas Regional Office
United States Patent and Trademark Office
As the Director of the Texas Regional United States Patent and Trademark Office (USPTO), Hope Shimabuku carries out the strategic direction of the Under Secretary of Commerce for Intellectual Prope...Show the rest
As the Director of the Texas Regional United States Patent and Trademark Office (USPTO), Hope Shimabuku carries out the strategic direction of the Under Secretary of Commerce for Intellectual Property and Director of the USPTO, and is responsible for leading the Texas regional office. Focusing on the region and actively engaging with the community, Ms. Shimabuku ensures the USPTO’s ini¬tiatives and programs are tailored to the region’s unique ecosystem of industries and stakeholders.
Ms. Shimabuku brings to the USPTO nearly two decades of experience as an engineer and intellectual property attorney. Most recently, Ms. Shimabuku was part of the Office of General Counsel at Xerox Corporation serving as Vice President and Corporate Counsel responsible for all intellectual property matters for Xerox Business Services, LLC. She also worked for BlackBerry Corpora¬tion advising on United States and Chinese standards setting, cyber security, technology transfer, and intellec¬tual property laws and legislation. As an engineer, she worked for Procter & Gamble and Dell Computer Corpo¬ration.
Ms. Shimabuku is a leader in the Texas region. She served as the Chair-Elect for the State Bar of Texas Intellectual Property Section and is a Barrister Member and Inaugural Member of the Barbara M.G. Lynn IP Inn of Court. She sat on the Board of Visitors for the Univer¬sity of North Texas Law School and served as a facilitator for the DFW Women in Intellectual Property group. She is a past president of the Dallas Asian American Bar Association, chaired the Dallas Diversity Task Force, and served on the board of the Dallas Bar Association and as a member of the Grievance Committee for the State Bar of Texas – District 6.
Throughout her career, Ms. Shimabuku has champi¬oned diversity efforts.Hide the rest
Cockrell School of Engineering The University of Texas at Austin
Dr. S.V. Sreenivasan is a Professor of Mechanical Engineering and the Joe C. Walter Endowed Chair in Engineering at The University of Texas at Austin. He received his Ph.D. in mechanical engineerin...Show the rest
Dr. S.V. Sreenivasan is a Professor of Mechanical Engineering and the Joe C. Walter Endowed Chair in Engineering at The University of Texas at Austin. He received his Ph.D. in mechanical engineering from The Ohio State University and a B. Engr. with Honors in mechanical engineering from the National Institute of Technology, Trichy, India. His research is in the area of high throughput nanomanufacturing as applied to electronics, photonics, flexible and wearable devices, terabit density data storage and emerging biomedical and clean energy applications. Dr. Sreenivasan has published over 100 technical articles and holds over 100 U.S. patents in the area of nanomanufacturing.Hide the rest